Posts by: Joana Carvalho

News

The anti-seizure effect of cannabidiol in Dravet syndrome is dependent on the type of neurons upon which it acts, but not on the activity of sodium channels, a study ... Read more

June 11, 2019June 11, 2019

Potassium Bromide Should be Considered for Treatment of Refractory Epilepsy, Study Says

News

Potassium bromide (KBr) can control certain types of epileptic seizures and should be considered as an option for the treatment of children with refractory epilepsy, a study says. The ... Read more

June 4, 2019June 4, 2019

Scientists Discover New Genetic Mutation Associated with Dravet Syndrome, Case Report Says

News

Scientists have found a new genetic mutation in the SCN1A gene associated with Dravet syndrome, a case report says. The genetic variant was described in the study, “A novel ... Read more

May 28, 2019May 28, 2019

AZD7325 Has Seizure-Protective Effect in Mouse Model of Dravet Syndrome, Study Says

News

Treatment with AZD7325, a compound that stimulates the activity of a specific type of receptors in the brain, has a seizure-protective effect in a mouse model of Dravet syndrome, ... Read more

May 10, 2019May 14, 2019

#AANAM – Epidiolex Reduces Frequency of Seizures in Children with Dravet Syndrome, Phase 3 Trial Shows

News

GW Pharmaceuticals‘ Epidiolex, the first plant-derived cannabidiol (CBD) medication to be approved by the U.S. Food and Drug Administration (FDA), reduces the frequency of epileptic seizures when used as an add-on therapy ... Read more

April 23, 2019April 23, 2019

Diacomit Tops List of Add-on Therapies to Control Epileptic Seizures in Children With Dravet, Review Study Says

News

Compared with its competitors, Diacomit (stiripentol) remains in the top position as an add-on therapy to control epileptic seizures in young children with Dravet syndrome, or in those who are affected ... Read more

April 16, 2019April 16, 2019

FDA Refuses New Drug Application for Zogenix’s Fintepla (ZX008)

News

The U.S. Food and Drug Administration (FDA) refused the New Drug Application (NDA) for Fintepla (ZX008), Zogenix‘s investigational anti-seizure therapy for patients with Dravet syndrome. According to statements from ... Read more

April 9, 2019April 9, 2019

Dravet Syndrome Patients Exhibit Variety of Gait Alterations, Review Finds

News

A wide variety of gait alterations have been reported for patients with Dravet syndrome, but the most common seems to be the crouch gait, a posture in which patients ... Read more

April 2, 2019April 2, 2019

Anti-seizure Effects of Cannabinoids May Benefit Some Neurological Disorders But Not Others, Review Study Says

News

Despite the promising anti-seizure effects of cannabinoids in children with Dravet syndrome and Lennox-Gastaut syndrome, more research is needed to understand how these compounds work and their potential benefits for ... Read more

March 14, 2019March 14, 2019

Multimodal Analysis is Best to Categorize SCN1A Genetic Variants, Study Says

News

Multimodal analysis that incorporates data obtained from different methodologies seems to be the best approach to build a solid classification system for SCN1A genetic variants associated with Dravet syndrome, ... Read more

Posts by: Joana Carvalho

Joana Carvalho

CBD’s Effect Depends on Neurons Involved, not Sodium Channels, Study Finds

Potassium Bromide Should be Considered for Treatment of Refractory Epilepsy, Study Says

Scientists Discover New Genetic Mutation Associated with Dravet Syndrome, Case Report Says

AZD7325 Has Seizure-Protective Effect in Mouse Model of Dravet Syndrome, Study Says

#AANAM – Epidiolex Reduces Frequency of Seizures in Children with Dravet Syndrome, Phase 3 Trial Shows

Diacomit Tops List of Add-on Therapies to Control Epileptic Seizures in Children With Dravet, Review Study Says

FDA Refuses New Drug Application for Zogenix’s Fintepla (ZX008)

Dravet Syndrome Patients Exhibit Variety of Gait Alterations, Review Finds

Anti-seizure Effects of Cannabinoids May Benefit Some Neurological Disorders But Not Others, Review Study Says

Multimodal Analysis is Best to Categorize SCN1A Genetic Variants, Study Says

Pin It on Pinterest